Crizotinib in ALK Rearranged Non-small-cell Lung Cancer

NCT04317651 · clinicaltrials.gov ↗

UNKNOWN

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Non Small Cell Lung Cancer
Advanced Cancer
Metastatic Cancer

Sponsor

Fondazione Ricerca Traslazionale